ACVBP-R regimen
WikiDoc Resources for ACVBP-R regimen |
Articles |
---|
Most recent articles on ACVBP-R regimen Most cited articles on ACVBP-R regimen |
Media |
Powerpoint slides on ACVBP-R regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on ACVBP-R regimen at Clinical Trials.gov Trial results on ACVBP-R regimen Clinical Trials on ACVBP-R regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on ACVBP-R regimen NICE Guidance on ACVBP-R regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on ACVBP-R regimen Discussion groups on ACVBP-R regimen Patient Handouts on ACVBP-R regimen Directions to Hospitals Treating ACVBP-R regimen Risk calculators and risk factors for ACVBP-R regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for ACVBP-R regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: Adriamycin-Cytoxan-Vindesine-Bleomycin-Prednisone-Rituximab Regimen
Overview
ACVBP-R regimen refers to a chemotherapy regimen consisting of doxorubicin, cyclophosphamide, vindesine, bleomycin, prednisone, and rituximab used in the treatment of non-Hodgkin lymphoma.
Regimen
ADoxorubicin (Adriamycin)
CCyclophosphamide
VVindesine
BBleomycin
PPrednisone
RRituximab
Indications
References
- ↑ Récher C, Coiffier B, Haioun C, Molina TJ, Fermé C, Casasnovas O; et al. (2011). "Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial". Lancet. 378 (9806): 1858–67. doi:10.1016/S0140-6736(11)61040-4. PMID 22118442.